A Randomized, Multicenter, Phase 2 Study of DSP-7888 Dosing Emulsion in Combination with Bevacizumab versus Bevacizumab Alone in Patients with Recurrent or Progressive Glioblastoma following Initial Therapy

June 23, 2018
https://clinicaltrials.gov/ct2/show/NCT03149003
Cancer - Brain
Principal Investigator: Tobias Walbert, MD
Glioblastoma, recurrent, progressive, brain cancer
Accepting Participants